Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug Macitentan

Strides Pharma Science arm secures USFDA nod for Gabapentin tablets for neuropathic pain treatment

Ruchika Sharma5 March 2024 4:11 PM IST

Gabapentin is an anticonvulsant medication primarily used to treat partial seizures and neuropathic pain.

Cadila Pharma unveils quadrivalent influenza vaccine Cadiflu Tetra

Ruchika Sharma5 March 2024 3:30 PM IST

New Delhi: Cadila Pharmaceuticals has said it has launched a vaccine to prevent influenza, a recurrent and widespread viral...

Cipla Bommasandra facility gets VAI classification from USFDA

Cipla gets CDSCO nod to market novel antibiotic Plazomicin in India, to launch under brand name Zemdri

Ruchika Sharma5 March 2024 12:11 PM IST

Mumbai: Cipla Limited has received approval from the Central Drugs Standard Control Organization (CDSCO) to market the novel antibiotic...

Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 million

Sandoz concludes acquisition of Cimerli business from Coherus BioSciences

Ruchika Sharma5 March 2024 10:30 AM IST

CIMERLI is indicated for the treatment of certain retinal diseases that, if left untreated, can cause vision loss, which ranks among the top 10 causes...

Bayer buys exclusive marketing rights for cardiology drug Acoramidis in Europe

Ruchika Sharma4 March 2024 3:30 PM IST

Under the terms of the agreement, BridgeBio and the affiliates will receive up to USD 310 million in upfront and near-term milestone payments and are...

SII boosts cervical cancer shots supply ahead of govt mass drive

Ruchika Sharma4 March 2024 2:43 PM IST

Poonawalla expects the vaccine to be "substantially, probably eight times, cheaper" when supplied to the government.

Dr Mansukh Mandaviya inaugurates 27 greenfield bulk drug park projects, 13 greenfield manufacturing plants for medical devices under the PLI Scheme

Ruchika Sharma4 March 2024 1:00 PM IST

New Delhi: Dr Mansukh Mandaviya, Union Minister for Chemicals & Fertilizers and Health & Family Welfare has virtually inaugurated 27...

Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban

Indoco Remedies arm commences commercial production of oral care products

Ruchika Sharma4 March 2024 11:51 AM IST

Mumbai: Warren Remedies Private Limited, a Wholly Owned Subsidiary of Indoco Remedies Limited has commenced its commercial production on March...

GSK CEO Emma Walmsley total remuneration rises 51 percent to USD 16 million in 2023

Ruchika Sharma4 March 2024 10:00 AM IST

London: GSK CEO Emma Walmsley's total remuneration rose 51 per cent to 12.7 million pounds ($16 million) in 2023, thanks to a big jump in...

USFDA approves Tonix Pharma Tonmya for fibromyalgia in adults

Boston Scientific secures USFDA okay for AGENT Drug-Coated Balloon to treat coronary in-stent restenosis

Ruchika Sharma3 March 2024 4:00 PM IST

Marlborough: Boston Scientific Corporation has announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT...

CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab Trial

Heartburn drug: GSK settles another lawsuit on Zantac in California

Ruchika Sharma3 March 2024 2:00 PM IST

The USFDA in 2020 pulled all brands named Zantac and generic versions of the drug off the market, triggering a wave of lawsuits.

RSV vaccine Abrysvo is protective through a second year: Pfizer

Ruchika Sharma3 March 2024 12:00 PM IST

New York: Pfizer has said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok